Compare LLYVA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLYVA | ALGN |
|---|---|---|
| Founded | 1991 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.5B |
| IPO Year | 2025 | 2000 |
| Metric | LLYVA | ALGN |
|---|---|---|
| Price | $102.22 | $159.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $185.79 |
| AVG Volume (30 Days) | 119.3K | ★ 1.0M |
| Earning Date | 02-26-2027 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 4.98 |
| Revenue | $381,951,000.00 | ★ $387,126,000.00 |
| Revenue This Year | $11.79 | $2.24 |
| Revenue Next Year | $7.17 | $2.86 |
| P/E Ratio | ★ N/A | $32.43 |
| Revenue Growth | 12.18 | ★ 23.95 |
| 52 Week Low | $74.38 | $132.64 |
| 52 Week High | $108.60 | $200.44 |
| Indicator | LLYVA | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 55.06 | 50.06 |
| Support Level | $93.31 | $149.55 |
| Resistance Level | $104.66 | $162.92 |
| Average True Range (ATR) | 2.87 | 6.09 |
| MACD | -0.13 | -0.57 |
| Stochastic Oscillator | 34.20 | 35.28 |
Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.